Merck Millipore appoints a new CEO, senior changes at Quintiles' Novella, and more.
Merck Millipore, the life sciences supplier known as EMD Millipore in the US and Canada, has announced its new President and CEO, Udit Batra. He will assume leadership on May 15 2014 from the company’s US headquarters in Massachusetts.
Batra, who holds a PhD in chemical engineering from Princeton University, moves to Merck Millipore from Merck KGaA’s Consumer Health division.
He previously worked as Head of Global Public Health and Market Access at Novartis Vaccines & Diagnostics, following several senior Novartis positions, including leading Corporate Strategy and the Australian business.
Batra’s early jobs included roles at Merck & Co. (MSD), McKinsey and Johnson & Johnson.
Copyright - Unless otherwise stated all contents of this web site are © 2014 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
Recipharm, Catalent, INC and PRA completed eye-catching IPOs in 2014. Which firms are likely follow suit in 2015?
Catering for low value, high volume customers as well as the growing number of firms developing complex...
Clinverse, Intertek and inVentiv are among the pharma services companies announcing new staff this week.